CN108795729B - A kind of biochip and its micro liquid sampling structure - Google Patents

A kind of biochip and its micro liquid sampling structure Download PDF

Info

Publication number
CN108795729B
CN108795729B CN201811135415.4A CN201811135415A CN108795729B CN 108795729 B CN108795729 B CN 108795729B CN 201811135415 A CN201811135415 A CN 201811135415A CN 108795729 B CN108795729 B CN 108795729B
Authority
CN
China
Prior art keywords
sample
cavity
quantity tube
hemofiltration
hematocrit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201811135415.4A
Other languages
Chinese (zh)
Other versions
CN108795729A (en
Inventor
邬鹏程
周孝祥
向苏民
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hunan Lezhun Biotechnology Co ltd
Original Assignee
Hunan Lok Zhixin Bio Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hunan Lok Zhixin Bio Technology Co Ltd filed Critical Hunan Lok Zhixin Bio Technology Co Ltd
Priority to CN201811135415.4A priority Critical patent/CN108795729B/en
Publication of CN108795729A publication Critical patent/CN108795729A/en
Application granted granted Critical
Publication of CN108795729B publication Critical patent/CN108795729B/en
Priority to PCT/CN2019/108336 priority patent/WO2020063795A1/en
Priority to EP19868007.6A priority patent/EP3858971A4/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells

Abstract

The invention discloses a kind of biochip and its micro liquid sampling structures, wherein micro liquid sampling structure includes quantity tube and hemofiltration structure, quantitative plunger is equipped at the top of quantity tube, quantity tube side wall upper part opens up the sample inlet communicated with quantitative tube cavity, and the bottom of quantity tube opens up sample exit port;The plasma outlet port of hemofiltration structure is connected with sample inlet.The present invention does not need discharge air and forms negative pressure absorbing sample, is easy to be directly integrated in small biochip;Not aeriferous fluid column can be formed in quantity tube in sample introduction, avoids bringing air in the reactor of biochip into, to the testing result of sample without any adverse effect;Red blood cell is not easy to plug filter membrane when prepared by plasma sample, and hemofiltration is abundant, and the hemofiltration time is short, high-efficient, red blood cell is oppressed that risk is low, and sample is not easy to be contaminated, and is particularly suitable for the preparation of biochip blood plasma test sample, testing cost is reduced, testing efficiency is improved.

Description

A kind of biochip and its micro liquid sampling structure
Technical field
The invention belongs to biochip test field, in particular to a kind of biochip and its micro liquid sampling structure.
Background technique
Existing micro liquid sampling structure includes quantity tube, in use, first excluding the air in quantity tube, then benefit Micro liquid is quantitatively drawn from certain container with principle of negative pressure to quantity tube, completes sample introduction process.When sampling, by quantity tube Displacement (mobile or rotation) recycles air that liquid is released quantity tube, achievees the purpose that sampling to designated position.
Existing this micro liquid sampling structure needs to shift in sampling process, thus is difficult or can not be integrated in micro- In small biochip.This mode is easy to draw air into quantity tube simultaneously, to can inevitably mix air in a liquid It releases, air is brought into the reactor of biochip, influences biochip to the testing result of sample.
In addition, in the prior art, the plasma sample preparation that biochip test is used all is using vertical hemofiltration form Hemofiltration structure, hemofiltration structure includes shell, and horizontal positioned filter membrane is equipped in shell, and cover top portion is equipped with opening up First cavity, shell is interior to be equipped with the second cavity being located at immediately below the first cavity, passes through between the first cavity and the second cavity Filter membrane connection.When hemofiltration, the first cavity is added in whole blood first, is then pressurizeed to the first cavity airtight, the small blood plasma of molecule will Filter membrane below the first cavity enters the second cavity, and the big red blood cell of molecule will be detained in the first cavity, to reach To the purpose of hemofiltration.
In above-mentioned this vertical hemofiltration structure, since red blood cell is detained in the first cavity and can be deposited on the first cavity On the filter membrane of bottom, with the progress of hemofiltration, the concentration of red blood cell is higher and higher in the first cavity, to be easy blocking filtering Film causes hemofiltration insufficient, and the time that the sample of filter unit amount needs is elongated, and efficiency reduces, it could even be possible to crushing red thin Born of the same parents cause sample to fail.
Summary of the invention
Existing micro liquid sampling structure needs to shift in sampling process, is difficult or can not be integrated in small biology In chip.It is easy sucking air in simultaneous quantitative pipe, air can inevitably be mixed and be released in a liquid, to bring air into life In the reactor of object chip, biochip is influenced to the testing result of sample.In addition, the blood plasma that existing biochip test is used Sample preparation is all the hemofiltration structure using vertical hemofiltration form, since red blood cell is detained in the first cavity and can be deposited on the On the filter membrane of the bottom of one cavity, with the progress of hemofiltration, the concentration of red blood cell is higher and higher in the first cavity, to be easy Blocking filter membrane causes hemofiltration insufficient, and the time that the sample of filter unit amount needs is elongated, and efficiency reduces, it could even be possible to pressure Broken red blood cell, causes sample to fail.It is an object of the present invention in view of the above shortcomings of the prior art, provide a kind of biological core Piece and its micro liquid sampling structure do not need discharge air and form negative pressure absorbing sample, be easy to be directly integrated in small life In object chip;Not aeriferous fluid column can be formed in quantity tube in sample introduction, avoids bringing air into the anti-of biochip into It answers in device, to the testing result of sample without any adverse effect;Meanwhile red blood cell is not easy to plug filtering when plasma sample preparation Film, hemofiltration is abundant, and the hemofiltration time is short, high-efficient, and it is low that red blood cell is oppressed risk.
In order to solve the above technical problems, the technical scheme adopted by the invention is that:
A kind of micro liquid sampling structure, including quantity tube and hemofiltration structure are structurally characterized in that at the top of the quantity tube Equipped with the quantitative plunger sealed to quantity tube bore seal, the quantity tube side wall upper part opens up the sample communicated with quantitative tube cavity The bottom of this inlet, quantity tube opens up sample exit port;The plasma outlet port of hemofiltration structure is connected with sample inlet.
By above structure, after Whole Blood Filtration is obtained plasma sample by hemofiltration structure, blood of the plasma sample from hemofiltration structure Slurry outlet by sample inlet is injected into quantitative tube cavity, since quantity tube upper end seals, lower ending opening, sample automatically into Quantitative tube cavity, in sample injection process, the air in quantity tube is continued to release from sample exit port by sample, and control injection is quantitative The sample size of tube cavity finally forms one section of not aeriferous sample fluid column in quantity tube, and providing for accurate quantitative sampling can Energy.Finally, pressing down on quantitative plunger, the sample in quantity tube can be released on demand.The present invention is empty due to not needing discharge Gas forms negative pressure absorbing sample, thus is easy to be directly integrated in small biochip;Due to that can be formed in quantity tube Not aeriferous fluid column, thus sample air entrainment enters in the reactor of biochip when sample-adding, to the testing result of sample Without any adverse effect.
Micro quantitative determination of the invention refer to the sampling sample size released from quantity tube sample exit port every time be 3 ul to 100ul。
The bottom of quantity tube is coniform as a preferred method, and sample exit port is set to quantitative bottom of the tube minimum point.This Air is discharged convenient for sample automatically into quantitative tube cavity and from bottom sample exit port in kind form, is more advantageous to be formed without air Sample fluid column.
As a preferred method, under initial sample introduction state, quantitative plunger bottom surface is coplanar with sample inlet highest point; Or quantitative plunger bottom surface is located between sample inlet the highest point and the lowest point.
When quantitative plunger bottom surface is located between sample inlet the highest point and the lowest point, it is more advantageous to be formed without air Sample fluid column.
Sample inlet open height is 1mm ~ 2.5mm, the middle section of quantity tube and the pipe of upper section as a preferred method, Diameter is 0.5mm ~ 3.5mm.The caliber of quantity tube is designed according to the viscosity of fluid (blood plasma), is discharged convenient for air when sample injection.
Further, the hemofiltration structure includes shell, and filter membrane is equipped in shell, and cover top portion is equipped with opening up First cavity, shell is interior to be equipped with the second cavity, is connected between the first cavity and the second cavity by filter membrane, filter membrane and level It is vertical between face;Second cavity is connected with sample inlet.
By above structure, due to vertical between filter membrane and horizontal plane, compared with the existing technology in filter membrane it is horizontal It places, the filter membrane in the present invention is vertically arranged in the first cavity side.During hemofiltration, even if red blood cell is trapped in first In cavity, since filter membrane is vertically arranged, since red blood cell is deposited on the first cavity bottom, thus red blood cell is not easy to plug setting Filter membrane in the first cavity side, thus blood plasma is more unobstructed by filter membrane, hemofiltration is abundant, and the hemofiltration time is short, high-efficient, It is low to be oppressed risk for red blood cell simultaneously.
Further, hematocrit chamber is additionally provided in shell, hematocrit chamber is connected with the first cavity bottom, hematocrit chamber it is small in size In the volume of the first cavity, hematocrit chamber is connected by filter membrane with the second cavity, and the volume of hematocrit chamber is greater than or equal to mistake Filter the total volume of red blood cell in whole blood.
By above structure, the first cavity bottom is connected with hematocrit chamber, and the intracorporal whole blood to be filtered of the first chamber continues past The intracavitary conveying of hematocrit, then blood plasma passes through filter membrane and enters the second cavity, and it is intracavitary that red blood cell is trapped in hematocrit, reaches hemofiltration mesh 's.It is red thin since the volume of hematocrit chamber is greater than or equal to the total volume of red blood cell in whole blood to be filtered, thus during hemofiltration Born of the same parents are deposited on hematocrit bottom of chamber portion, and hematocrit chamber upper space is reserved for receiving the whole blood newly injected, and filter membrane is more not easy red Cell blocking, hemofiltration are more unobstructed.
Further, further including can be to the hemofiltration plunger of the first cavity top opening pressurizing window.
When hemofiltration, driving force is applied to hemofiltration plunger using driving mechanism, so that hemofiltration plunger adds the first cavity airtight Pressure promotes whole blood to flow toward filter membrane direction, reaches hemofiltration purpose.
The hematocrit chamber connects the highest of the highest point side corresponding thereto of side with filter membrane as a preferred method, Point is in same level;Alternatively, the hematocrit chamber connects with filter membrane, the highest point of side is higher than the highest of its opposite flank Point.
Hematocrit chamber connect with filter membrane side highest point be higher than its opposite flank highest point in the case of, filter membrane is less Easily it is blocked.
It further include described the present invention also provides a kind of biochip, including reactor based on the same inventive concept Micro liquid sampling structure, the sample exit port are located above reactor.
Compared with prior art, the present invention does not need discharge air and forms negative pressure absorbing sample, is easy to be directly integrated in micro- In small biochip;Not aeriferous fluid column can be formed in quantity tube in sample introduction, avoids bringing air into biological core into In the reactor of piece, to the testing result of sample without any adverse effect;Meanwhile red blood cell is not easy to plug when plasma sample preparation Filter membrane, hemofiltration is abundant, and the hemofiltration time is short, high-efficient, and red blood cell is oppressed that risk is low, and sample is not easy to be contaminated, especially suitable In the preparation of biochip blood plasma test sample, testing cost is greatly reduced, improves testing efficiency.
Detailed description of the invention
Fig. 1 is the structural schematic diagram of one embodiment of micro liquid sampling structure.
Fig. 2 is to insert filter membrane schematic diagram toward shell insert port.
Wherein, 1 is shell, and 101 be the first cavity, and 102 be the second cavity, and 103 be hematocrit chamber, and 104 be insert port, and 2 are Filter membrane, 3 be hemofiltration plunger, and 4 be quantity tube, and 401 be sample inlet, and 402 be sample exit port, and 5 be quantitative plunger.
Specific embodiment
As shown in Figure 1, micro liquid sampling structure includes quantity tube 4 and hemofiltration structure, it is equipped at the top of the quantity tube 4 pair The quantitative plunger 5 of 4 bore seal of quantity tube sealing, 4 side wall upper part of quantity tube open up the sample communicated with 4 inner cavity of quantity tube Inlet 401, the bottom of quantity tube 4 open up sample exit port 402;The plasma outlet port of hemofiltration structure is connected with sample inlet 401 It is logical.Quantitative plunger 5 can select different material and thickness as needed.
After Whole Blood Filtration is obtained plasma sample by hemofiltration structure, plasma sample passes through sample from the plasma outlet port of hemofiltration structure Inlet 401 is injected into 4 inner cavity of quantity tube, and due to the sealing of 4 upper end of quantity tube, lower ending opening, sample is automatically into quantity tube 4 Chamber, in sample injection process, the air in quantity tube 4 is continued to release from sample exit port 402 by sample, control injection quantity tube 4 The sample size of inner cavity finally forms not aeriferous sample fluid column in quantity tube 4, provides possibility for accurate quantitative sampling.Most Afterwards, quantitative plunger 5 is pressed down on, can on demand be released the sample in quantity tube 4.The present invention is not due to needing discharge air shape At negative pressure absorbing sample, thus it is easy to be directly integrated in small biochip;It is free of due to that can be formed in quantity tube 4 The fluid column of air, thus sample air entrainment when sample introduction is avoided to enter in the reactor of biochip, to the testing result of sample Without any adverse effect.
The bottom of quantity tube 4 be it is coniform, sample exit port 402 be set to 4 bottom minimum point of quantity tube.Such form is convenient for sample Air is discharged automatically into 4 inner cavity of quantity tube and from bottom sample exit port 402 in this, is more advantageous to form not aeriferous sample liquid Column.
Under initial sample introduction state, 5 bottom surface of quantitative plunger is coplanar with 401 highest point of sample inlet;Or quantitative plunger 5 Bottom surface is located between 401 the highest point and the lowest point of sample inlet.When 5 bottom surface of quantitative plunger is located at 401 highest of sample inlet When between point and minimum point, it is more advantageous to form not aeriferous sample fluid column.
401 open height of sample inlet is 1mm ~ 2.5mm, the caliber of the middle section of quantity tube 4 and upper section be 0.5mm ~ 3.5mm.The caliber of quantity tube is designed according to the viscosity of fluid (blood plasma), is discharged convenient for air when sample injection.Except in embodiment Outside the structure, quantity tube 5 can also use other structures, such as rectangular parallelepiped structure.
The quantity tube 4 is made by hydrophobic material.
The inner surface of the quantity tube 4 is mirror surface.
The hemofiltration structure includes shell 1, and filter membrane 2 is equipped in shell 1, is equipped with opening up first at the top of shell 1 Cavity 101, shell 1 is interior to be equipped with the second cavity 102, is connected between the first cavity 101 and the second cavity 102 by filter membrane 2, mistake It is vertical between filter membrane 2 and horizontal plane;Second cavity 102 is connected with sample inlet 401.Hematocrit chamber is additionally provided in shell 1 103, hematocrit chamber 103 is connected with 101 bottom of the first cavity, volume of the volume less than the first cavity 101 of hematocrit chamber 103, pressure Product chamber 103 is connected by filter membrane 2 with the second cavity 102, and the volume of hematocrit chamber 103 is greater than or equal to red in whole blood to be filtered The total volume of cell.Preferably, vertical between filter membrane 2 and horizontal plane.
By the demand to plasma volume is obtained by filtration, the volume of whole blood to be filtered can be calculated, and then is obtained red in whole blood The total volume of cell.Such as: if desired 20 microlitres of blood plasma, due to probably there was only 40 ~ 50% blood plasma in the whole blood of people, then 50 microlitres of whole blood is at least needed, there is 25 ~ 30 microlitres of red blood cell in 50 microlitres of whole blood, thus the volume of hematocrit chamber 103 is 25 ~ 30 microlitres or be slightly larger than this value.
Hematocrit chamber 103 can be the regular shapes such as square, cuboid, or anomalistic object.
Due to vertical between filter membrane 2 and horizontal plane, compared with the existing technology in filter membrane 2 it is horizontal positioned, the present invention In filter membrane 2 be vertically arranged in 103 side of hematocrit chamber.First cavity, 101 bottom is connected with hematocrit chamber 103, the first cavity Whole blood to be filtered in 101 continues the conveying in hematocrit chamber 103, and then blood plasma enters the second cavity 102 across filter membrane 2, red Cellular retention reaches hemofiltration purpose in hematocrit chamber 103.
Since the volume of hematocrit chamber 103 is greater than or equal to the total volume of red blood cell in whole blood to be filtered, thus in hemofiltration mistake Cheng Zhong, red blood cell are deposited on 103 bottom of hematocrit chamber, and 103 upper space of hematocrit chamber is reserved for receiving the whole blood newly injected, due to Filter membrane 2 is vertically arranged in 103 side of hematocrit chamber, and filter membrane 2 is not easy to be blocked by red blood cell, and hemofiltration is more unobstructed, and hemofiltration is abundant, filter The blood time is short, high-efficient, while to be oppressed risk low for red blood cell.
Hemofiltration structure further includes can be to the hemofiltration plunger of the first cavity top opening pressurizing window.
When hemofiltration, driving force is applied to hemofiltration plunger 3 using driving mechanism, so that hemofiltration plunger 3 is close to the first cavity 101 Pressurization is closed, promotes whole blood to flow toward 2 direction of filter membrane, reaches hemofiltration purpose.
In the present embodiment, the hematocrit chamber 103 connects the highest of the highest point side corresponding thereto of side with filter membrane 2 (connect with filter membrane 2 highest point of side of the hematocrit chamber 103 can be above its opposite flank to point in same level Highest point is not shown in the accompanying drawings, but has no effect on those skilled in the art's the understanding of the present invention and realization.In hematocrit chamber 103 highest points for connecting side with filter membrane 2 are higher than in the case of the highest point of its opposite flank, and filter membrane 2 is less susceptible to be blocked Plug).
The insert port 104 for inserting the filter membrane 2 is opened up on the shell 1.In Fig. 2, the insert port 104 is opened up In 1 side wall of shell, insert port 104 can also be opened in 1 top of shell or bottom.
It further include the micro liquid sampling structure, institute the present invention also provides a kind of biochip, including reactor Sample exit port 402 is stated to be located above reactor.
The embodiment of the present invention is described with above attached drawing, but the invention is not limited to above-mentioned specific Embodiment, the above mentioned embodiment is only schematical, rather than limitation, those skilled in the art Under the inspiration of the present invention, without breaking away from the scope protected by the purposes and claims of the present invention, it can also make very much Form, within these are all belonged to the scope of protection of the present invention.

Claims (8)

1. a kind of micro liquid sampling structure, including quantity tube (4) and hemofiltration structure, which is characterized in that quantity tube (4) top Portion is equipped with the quantitative plunger (5) sealed to quantity tube (4) bore seal, and quantity tube (4) side wall upper part opens up and quantity tube (4) the sample inlet (401) that inner cavity communicates, the bottom of quantity tube (4) open up sample exit port (402);The blood plasma of hemofiltration structure Outlet is connected with sample inlet (401);
The hemofiltration structure includes shell (1), is equipped with filter membrane (2) in shell (1), is equipped at the top of shell (1) opening up First cavity (101), shell (1) is interior to be equipped with the second cavity (102), passes through between the first cavity (101) and the second cavity (102) Filter membrane (2) connection, it is vertical between filter membrane (2) and horizontal plane;Second cavity (102) is connected with sample inlet (401).
2. micro liquid sampling structure as described in claim 1, which is characterized in that the bottom of quantity tube (4) is coniform, sample This outlet (402) is set to quantity tube (4) bottom minimum point.
3. micro liquid sampling structure as described in claim 1, which is characterized in that under initial sample introduction state, quantitative plunger (5) bottom surface is coplanar with sample inlet (401) highest point;Or quantitative plunger (5) bottom surface is located at sample inlet (401) highest Between point and minimum point.
4. micro liquid sampling structure as described in claim 1, which is characterized in that sample inlet (401) open height is 1mm ~ 2.5mm, the middle section of quantity tube (4) and the caliber of upper section are 0.5mm ~ 3.5mm.
5. micro liquid sampling structure as described in claim 1, which is characterized in that be additionally provided with hematocrit chamber in shell (1) (103), hematocrit chamber (103) is connected with the first cavity (101) bottom, and the volume of hematocrit chamber (103) is less than the first cavity (101) Volume, hematocrit chamber (103) is connected by filter membrane (2) with the second cavity (102), the volume of hematocrit chamber (103) be greater than or Equal to the total volume of red blood cell in whole blood to be filtered.
6. micro liquid sampling structure as described in claim 1, which is characterized in that further include that can be pushed up to the first cavity (101) The hemofiltration plunger (3) of portion's opening pressurizing window.
7. micro liquid sampling structure as claimed in claim 5, which is characterized in that the hematocrit chamber (103) and filter membrane (2) Connect side highest point side corresponding thereto highest point in same level;Alternatively, the hematocrit chamber (103) and filtering Film (2) connect side highest point be higher than its opposite flank highest point.
8. a kind of biochip, including reactor, which is characterized in that further include as described in any one of claim 1 to 7 micro Liquid sample introduction structure, the sample exit port (402) are located above reactor.
CN201811135415.4A 2018-09-28 2018-09-28 A kind of biochip and its micro liquid sampling structure Active CN108795729B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
CN201811135415.4A CN108795729B (en) 2018-09-28 2018-09-28 A kind of biochip and its micro liquid sampling structure
PCT/CN2019/108336 WO2020063795A1 (en) 2018-09-28 2019-09-27 Biochip, micro liquid sample loading structure thereof, and micro quantitative sampling method
EP19868007.6A EP3858971A4 (en) 2018-09-28 2019-09-27 Biochip, micro liquid sample loading structure thereof, and micro quantitative sampling method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811135415.4A CN108795729B (en) 2018-09-28 2018-09-28 A kind of biochip and its micro liquid sampling structure

Publications (2)

Publication Number Publication Date
CN108795729A CN108795729A (en) 2018-11-13
CN108795729B true CN108795729B (en) 2019-02-05

Family

ID=64082265

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811135415.4A Active CN108795729B (en) 2018-09-28 2018-09-28 A kind of biochip and its micro liquid sampling structure

Country Status (1)

Country Link
CN (1) CN108795729B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3858971A4 (en) * 2018-09-28 2021-11-17 Hunan Legend Ai Chip Biotechnology Co., Ltd. Biochip, micro liquid sample loading structure thereof, and micro quantitative sampling method
CN111999488A (en) * 2019-05-11 2020-11-27 南京岚煜生物科技有限公司 Quantitative method convenient for whole blood detection
CN110058007A (en) * 2019-05-12 2019-07-26 南京岚煜生物科技有限公司 Single channel micro-fluidic chip
CN111707507B (en) * 2020-06-23 2023-02-28 合肥安为康医学检验有限公司 Biochemical quantitative detection device of blood sample
CN111829826A (en) * 2020-06-24 2020-10-27 温州医科大学 Blood sample extraction device for gene marker detection
CN111939599B (en) * 2020-07-14 2024-01-12 山东中保康医疗器具有限公司 Method and device for preparing platelet-rich plasma

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60119133T2 (en) * 2000-07-31 2007-01-25 Matsushita Electric Industrial Co., Ltd., Kadoma BIOSENSOR
EP2637788A1 (en) * 2010-11-10 2013-09-18 Boehringer Ingelheim Microparts GmbH Device for filtering blood
CN203350078U (en) * 2013-07-19 2013-12-18 杭州中肽生化有限公司 Rapid detection device for liquid sample
CN205426562U (en) * 2015-12-21 2016-08-03 天津市正江高科技有限公司 Blood serum sampler
CN206868242U (en) * 2017-04-01 2018-01-12 南京岚煜生物科技有限公司 Micro-fluidic chip based on the flowing of active control liquid
CN107199061B (en) * 2017-05-28 2021-07-27 合肥赫博医疗器械有限责任公司 Application method of multi-task full-automatic biochemical detection chip

Also Published As

Publication number Publication date
CN108795729A (en) 2018-11-13

Similar Documents

Publication Publication Date Title
CN108795729B (en) A kind of biochip and its micro liquid sampling structure
US6176903B1 (en) Device for removing gases from fluids
US9283313B2 (en) Device and filter cartridge for separating plasma from whole blood
JPH09500809A (en) Self-prepared filter device
CN208109479U (en) A kind of micro quantitative determination sampling system
EP2264453A1 (en) Blood filter and method for filtering blood
CN109358189A (en) A kind of biochip and its micro quantitative determination sampling method
US20080312576A1 (en) Plunger-less syringe for controlling blood flow
CN102350014B (en) Infusion set
CN113122613B (en) Totally-enclosed fluorescent quantitative PCR microfluidic detection chip
CN209549518U (en) Whole Blood Filtration and blood plasma quantify micro-fluidic chip
WO2020063795A1 (en) Biochip, micro liquid sample loading structure thereof, and micro quantitative sampling method
CN109238777A (en) Biochip micro quantitative determination sampling system
CN206248404U (en) Underground water dissolved gas on-site sampler
CN205538343U (en) Dirt mite allergen detection device
CN212844531U (en) Urine sample collection device
CN102295259B (en) High-pressure fluid injection apparatus with automatic bubble discharging function
CN106769244A (en) Underground water dissolved gas on-site sampler
CN208109499U (en) A kind of micro liquid sampling structure
JP2022073908A (en) Apparatuses, systems and methods for sample capture and extraction
CN108392851A (en) A kind of Chinese medicine supercritical extraction unit
CN208104413U (en) A kind of side hemofiltration structure and biochip
CN212646246U (en) Sample treatment cup and urine iodine detecting instrument
CN206328364U (en) Schlempe filter
CN108543328A (en) A kind of Chinese medicine supercritical extraction method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP03 Change of name, title or address

Address after: 410221 Room 601, No. 239, Linyu Road, Changsha High-tech Development Zone, Changsha, Hunan Province

Patentee after: Hunan Lezhun Biotechnology Co.,Ltd.

Address before: Room 2001-2003, building F1, luguyuyuan, 27 Wenxuan Road, Changsha hi tech Development Zone, Changsha City, Hunan Province, 410205

Patentee before: HUNAN LEGEND AI CHIP BIOTECHNOLOGY Co.,Ltd.

CP03 Change of name, title or address